LOUISVILLE, Ky. — The 152nd Kentucky Derby is set for Saturday at Churchill Downs, with post time scheduled for 6:57 p.m. ET in the signature race of the Triple Crown season. A field of 20 three-year-olds will vie for the garland of roses in the $5 million Run for the Roses, promising one of the most anticipated — and heavily wagered — days in American sports.
2026 Kentucky Derby Predictions: Expert Picks, Favorites and Odds for Historic Run for the Roses
Renegade, trained by Todd Pletcher and ridden by Irad Ortiz Jr., drew the rail and opened as the 4-1 morning-line favorite after an impressive Arkansas Derby victory. Other top contenders include Commandment and Further Ado at around 6-1, Chief Wallabee near 8-1, and So Happy and The Puma in single digits. Odds will fluctuate until race time as betting action intensifies.
The race shapes up as wide-open, with strong opinions on both sides of the favorite. Experts highlight a mix of speed, stamina and tactical versatility across the field, drawn from key prep races including the Florida Derby, Louisiana Derby, Blue Grass and others. Cool, dry conditions are forecast, favoring a fast track that could produce blistering times in the 1¼-mile classic.
Renegade brings elite credentials but faces the dreaded inside post, which historically challenges horses in large fields. Pletcher, a multiple Derby winner, has the colt sharp, yet some handicappers worry about rail position and early traffic. Commandment, from the Brad Cox barn, impressed in Florida and could stalk or close effectively with Luis Saez aboard. Further Ado, breaking from post 17 or 18, offers outside speed or mid-pack versatility depending on the early pace scenario.
Value plays abound. Emerging Market, trained by Chad Brown, has limited but high-quality starts and could offer a price around 15-1. Danon Bourbon represents strong Japanese influence and international interest at double-digit odds. Chief Wallabee, another Cox trainee, and The Puma, an improving Gustavo Delgado charge, also draw attention as potential upset candidates.
Advertisement
Jody Demling, who nailed a lucrative superfecta in a prior Derby, is among those fading the top choice. He points to The Puma’s consistency and a longshot “freak” with upside in exotics. Other experts, including those from BloodHorse and Horse Racing Nation, lean toward Commandment or Further Ado on top, with Emerging Market frequently appearing in top-three lists for its tactical flexibility.
The full projected field, subject to final scratches, features a blend of established stars and live longshots:
Post 1: Renegade (4-1 to 5-1), Pletcher/Ortiz Jr. — Speedy Arkansas Derby winner but rail concerns loom.
Post 6: Commandment (6-1 to 7-1), Cox/Saez — Florida form gives him a strong shot to stalk and pounce.
Post ~17-18: Further Ado (6-1), strong closer with stamina for the distance.
Post 9 or so: The Puma (5-1 to 10-1) — Late bloomer undefeated or near in recent starts.
Chief Wallabee (8-1), So Happy (6-1), Danon Bourbon (~14-1), Emerging Market (~13-1) and others round out a competitive group.
Scratches have already adjusted the lineup, with horses like Fulleffort and Silent Tactic out, bringing in alternates such as Great White or Ocelli. The 20-horse gate ensures chaos, where post position, pace and jockey decisions often decide the outcome.
Handicapping angles focus on the Road to the Kentucky Derby points system, which qualified the top earners. Prep races highlighted closers and versatile types over pure speed. Brad Cox holds a powerful hand with multiple live contenders, while international bloodlines add depth. Weather and track bias will play roles — a dry forecast favors speed but middle and late runners have succeeded in recent editions.
Betting interest is expected to shatter records. Win bets on favorites, exactas, trifectas and superfectas will dominate, with exotic wagers offering massive payouts in a 20-horse scrum. TwinSpires and other platforms report heavy early action on Renegade, Commandment and value horses like Danon Bourbon.
Advertisement
Beyond the wagering, the Derby embodies tradition. Mint juleps, extravagant hats and celebrity sightings will fill the Churchill Downs infield and grandstand. The event kicks off a whirlwind May leading to the Preakness and Belmont, with potential for the first Triple Crown in years if a horse sweeps the series.
Experts’ consensus top picks vary but cluster around a few:
Win contenders: Commandment or Further Ado for many, citing tactical advantages and proven stakes form.
Place/show: The Puma, Chief Wallabee or Emerging Market for value.
Longshots: Danon Bourbon, Incredibolt or Pavlovian could crash the exotics at big prices.
One prominent handicapper likes boxing Commandment, The Puma and a closer with Emerging Market underneath. Another emphasizes Florida preps and international upside with Danon Bourbon at 20-1 range. Fading the favorite entirely is a bold but discussed strategy given the rail and large field dynamics.
The Derby’s unpredictability is legendary — longshots like Rich Strike (80-1) and Country House (via disqualification) remind bettors that pedigree, training and race-day luck trump morning-line odds. This year’s class appears deep, with no runaway standout, setting up for a memorable stretch duel.
Churchill Downs officials emphasize safety and fan experience, with enhanced security and sustainability initiatives. NBC and Peacock will broadcast nationwide, bringing the pageantry to millions.
Advertisement
As horses ship in and final workouts conclude, anticipation builds. Renegade’s rail draw adds intrigue — can he overcome history? Will a closer steal the show in the final furlongs? Or does an overlooked mid-pack runner deliver the upset?
Whatever the result, the 2026 Kentucky Derby promises drama, high stakes and the enduring magic of the Sport of Kings. Bettors and fans alike will remember where they were when the gates spring open and the call of “And they’re off!” echoes through Louisville.
For those planning wagers, key strategies include focusing on horses with proven 1¼-mile stamina, favorable post positions away from the rail for traffic avoidance, and trainers with Derby success. Value exists beyond the top three morning-line choices, particularly in exotics where layering 8-1 to 20-1 horses can yield strong returns.
The Road to the Roses delivered a compelling group this year. From dominant prep wins to gritty recoveries, each contender has a story. On Saturday, only one will wear the roses — but the debate and memories will last far longer.
Advertisement
Post-race analysis will dissect every move, but pre-race, the consensus expert lean favors tactical versatility over pure favoritism. Commandment, Further Ado and live prices like Emerging Market or Chief Wallabee top many professional tickets.
The Kentucky Derby remains horse racing’s crown jewel, blending athletic excellence, strategy and sheer spectacle. This year’s edition, with its balanced field and star trainers, is poised to deliver.
Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team
OKLAHOMA CITY — As Luka Doncic continues his recovery from a Grade 2 left hamstring strain with no return date set for the Western Conference semifinals, Fox Sports commentator Skip Bayless sparked intense debate by claiming the Los Angeles Lakers are actually playing better without their star acquisition and labeling the Slovenian guard “the most inefficient player in the league.”
Luka Doncic
Bayless made the provocative statement on his show “Undisputed” on Thursday morning, just hours before the Lakers prepared for Game 3 against the Oklahoma City Thunder. “Look at the numbers. Look at the eye test. The Lakers are moving better, playing harder, and looking more cohesive without Luka,” Bayless said. “He is the most inefficient player in the league right now. The turnovers, the hero ball — they’re better off without him.”
The comments quickly went viral, drawing sharp criticism from NBA fans, players and analysts who pointed to Doncic’s elite production before the injury. Doncic averaged 33.5 points, 8 rebounds and 9 assists per game this season before suffering the hamstring injury on April 2. His absence has left the Lakers struggling, as they trail the Thunder 2-0 in the series.
Doncic has been progressing in his rehabilitation but remains sidelined. He has begun running and light on-court work, but the Lakers have ruled him out for Game 3 on Friday night at Crypto.com Arena. The original eight-week timeline from his initial MRI would push any potential return into late May. The team continues to manage his recovery cautiously to avoid re-injury.
Bayless Doubles Down on Criticism
Bayless, known for his polarizing takes, doubled down during the show, citing advanced metrics. “Look at his true shooting percentage, his assist-to-turnover ratio in big moments. The numbers don’t lie,” he said. “LeBron is playing like it’s 2018 again without having to babysit Luka’s inefficiency.”
Advertisement
The remarks ignited immediate backlash. Former NBA players and current analysts pushed back strongly on social media. “Skip has lost it,” tweeted one retired star. “Luka is a top-5 player when healthy. This is just nonsense for clicks.”
LeBron James, when asked about the comments after practice, offered a measured response. “Skip is going to say what he says. I focus on what we do as a team. Luka is a special player, and we miss him,” James said. Coach JJ Redick also dismissed the narrative. “Luka is one of the best players in the world. When he’s healthy, he makes us better. Period,” Redick stated.
Lakers Struggling Without Doncic
The Lakers have looked disjointed without their Slovenian star. In Games 1 and 2, Oklahoma City exploited turnovers and defensive lapses, winning convincingly. James has shouldered a heavy load, averaging nearly 28 points, but the supporting cast has struggled to create consistent offense. Austin Reaves and Rui Hachimura have provided contributions, but the team clearly misses Doncic’s playmaking and floor spacing.
Analysts note that while the Lakers have shown occasional flashes of competitiveness, the talent gap against the deeper, more athletic Thunder has been evident. Without Doncic’s gravity and ability to draw double teams, opposing defenses have been able to load up on James and Reaves.
Advertisement
Injury Details and Recovery Timeline
Doncic suffered the Grade 2 hamstring strain in the regular-season finale. The injury involves a partial tear that typically requires four to eight weeks. He traveled to Spain for specialized PRP injections shortly after the diagnosis. While PRP is a common treatment, some sports medicine experts have questioned whether more advanced regenerative options could have accelerated his recovery.
The Lakers have taken a conservative approach. Doncic has progressed to running and shooting drills but has not participated in full-contact work. An eight-week timeline from early April points to late May availability. If the Lakers advance past the Thunder, he could potentially return for the Western Conference finals. However, most insiders consider a return in the current series highly unlikely.
Broader Debate on Efficiency and Team Fit
Bayless’s comments have reignited discussions about player efficiency and team chemistry. Critics point to Doncic’s high usage rate and occasional turnover issues, while supporters highlight his elite scoring, passing and ability to elevate teammates. Advanced metrics show Doncic’s positive impact on winning when healthy, with the Lakers posting a strong net rating in games he played this season.
NBA analysts note that high-usage stars like Doncic often appear less efficient due to the volume of difficult shots they create. His playmaking opens up opportunities for teammates, even if the raw assist-to-turnover numbers sometimes draw criticism.
Advertisement
LeBron James has publicly defended his teammate multiple times. “Luka is a genius on the basketball court,” James said earlier in the season. “The way he sees the game is special.”
Lakers’ Path Forward
With Doncic sidelined, the Lakers must find ways to increase scoring and defensive intensity. Redick has experimented with different lineups, emphasizing pace and three-point volume. Home-court energy at Crypto.com Arena for Game 3 will be crucial as the Lakers try to avoid falling into a 3-0 deficit.
If the series extends, the hope remains that Doncic can return and provide the spark needed to challenge the Thunder. However, medical staff continue to prioritize long-term health over short-term desperation.
What the Future Holds
The Doncic injury and the surrounding debate have highlighted the Lakers’ reliance on star power. The blockbuster trade that brought him to Los Angeles was meant to create a championship window with James, but injuries have tested those plans.
Advertisement
As the series continues, all eyes remain on Doncic’s recovery timeline and the Lakers’ ability to compete without him. Bayless’s comments, whether provocative or insightful, have added fuel to an already intense playoff narrative. For now, the focus for the Lakers is survival — with or without their Slovenian superstar.
Doncic himself has expressed frustration with the slow progress but remains committed to returning stronger. “I just want to help my team win,” he said in his last public comments. As the Lakers prepare for Game 3, the basketball world watches to see if LeBron James and company can find answers against a Thunder team built for sustained contention.
Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team
Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team
Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team
| Revenue of $464.89M (7.71% Y/Y) misses by $157.42M
This article was written by
Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team
BioVie Inc. (BIVI) Discusses Bezisterim’s Mechanism of Action and Its Potential in Addressing Parkinson’s Disease Pathology May 7, 2026 2:00 PM EDT
Company Participants
Cuong Viet Do – President, CEO & Director Joseph Palumbo – Executive VP of R&D and Chief Medical Officer Clarence Ahlem – Senior Vice President of Operations
Advertisement
Conference Call Participants
Suzanne de la Monte
Presentation
Advertisement
Operator
Good afternoon, and welcome to the BioVie Virtual KOL event. [Operator Instructions]
As a reminder, this call is being recorded, and a replay will be made available on the BioVie website following the conclusion of the event. Please refer to this slide about forward-looking statements, which describe the disclaimers and risk factors related to such statements and consult BioVie’s public filings made with the Securities and Exchange Commission that can be found at www.sec.gov. With that, I’d like to now turn the call over to Cuong Do, Chief Executive Officer of BioVie. Please go ahead, Cuong.
Advertisement
Cuong Viet Do President, CEO & Director
Thank you, Serra. Thank you, everyone, for joining today. My name is Cuong Do. I’m the President and CEO of BioVie. I’d just like to take a few minutes to give everyone an update on where we stand with our 2 clinical trials. Our first trial, of course, is in Parkinson’s. That trial is nearly complete. The last patient has come in for his last visit. So our team is working through the study closeout process right now to basically go through all the data to clean up the data and so forth.
But most importantly, we needed to wait for the biomarker data to come back in. We are hoping to have everything in and analyzed by the end of this quarter, but it may slip into next quarter depending on how long it takes for us to get
Good morning, ladies and gentlemen, and welcome to the Gibraltar Industries First Quarter 2026 Financial Results Conference Call. [Operator Instructions] This call is being recorded on Thursday, May 7, 2026.
I would now like to turn the conference over to Carolyn Capaccio. Please go ahead.
Advertisement
Carolyn Capaccio Alliance Advisors, LLC
Thanks, Joanna. Good morning, everyone, and thank you for joining us today. With me on the call is Bill Bosway, Gibraltar Industries’ Chairman, President and Chief Executive Officer; and Joe Lovechio, Gibraltar’s Chief Financial Officer. The earnings press release that was issued this morning as well as the slide presentation that management will use during the call are both available in the Investors section of the company’s website, gibraltar1.com.
Gibraltar’s earnings press release and remarks contain non-GAAP financial measures. Tables of reconciliation of GAAP to adjusted financial measures can be found in the earnings press release that was issued today. Further, please note that continuing operations exclude net sales and operating results of the Renewables business, which was classified as held for sale and as a discontinued operation with second quarter 2025 results, the eBOS portion of which was subsequently sold on February 20, 2026. The acquisition of OmniMax International closed on February 2, 2026.
Also, as noted on Slide 2 of the presentation, the earnings press release and slide presentation contain forward-looking statements with respect to future financial results. These statements are not guarantees of future performance, and the company’s actual
You must be logged in to post a comment Login